• 검색 결과가 없습니다.

[PDF] Top 20 Efficacy of Entecavir in Patients with Hepatitis B virus-Related Decompensated Liver Cirrhosis

Has 10000 "Efficacy of Entecavir in Patients with Hepatitis B virus-Related Decompensated Liver Cirrhosis" found on our website. Below are the top 20 most common "Efficacy of Entecavir in Patients with Hepatitis B virus-Related Decompensated Liver Cirrhosis".

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.

... s of rtM204 sequences,and LAM was swi tched to ADV ...None of the pati ent had co-i nfecti ons(HCV, HIV) or other concomi tantl i verdi seasesuchasal cohol i cl i verdi seaseorautoi mmunel i ver di ... See full document

30

Efficacy of entecavir verses lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with allogeneic stem cell transplant

Efficacy of entecavir verses lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with allogeneic stem cell transplant

... Sixty patients, thirty in each group who received LVD or ETV prophylaxis were included in the ...duration of prophylaxis of each drugs and clinical and virological follow up post ... See full document

1

Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies

Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies

... term efficacy of ADV-based combination therapies, ...CHB patients with genotypic resistance to ...rates of virological response in patients treated with ADV/ETV vs ... See full document

10

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

... limit of real-time poly- merase chain reaction as the primary treatment ...combination of ETV-based regimens had been attempted to treat the CHB patients who had suboptimal response to LAM or LdT/ADV ... See full document

3

Changes in serum histologic surrogate markers and procollagen III N- terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy

Changes in serum histologic surrogate markers and procollagen III N- terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy

... loss of HBeAg; however, this is based on minimal evidence and most therapeutic trials have used loss of HBeAg as a therapeutic ...losses in conjunction with undetectable HBV DNA are reasonable ... See full document

35

Peginterferon alpha and ribavirin combination therapy in
patients with hepatitis C virus-related liver cirrhosis

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis

... cirrhotic patients, the SVR rate of the genotype non-1 group was similar at around ...SVRs of genotype 1 group was reported to be very low at 13-14%, 14,15 however, the SVR was relatively high at ... See full document

6

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis

... hepatectomy patients with HCV-related HCC were prospectively identified at our institution be- tween July 2005 and May ...hepatectomy patients had HCC in a non-cirrhotic ...better ... See full document

1

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients

... 2015, patients with HBV who underwent LT (both living-donor LT [LDLT] and deceased-donor LT [DDLT]) at Samsung Medical Center (Seoul, Republic of Korea) were ...HCC, liver cirrhosis, ... See full document

8

Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world

Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world

... evaluated patients diagnosed with HCV genotype 1b infection who received DCV and ASV combination therapy between August 2015 and March 2017 at five university hospitals in Daegu and Gyeong- ... See full document

8

Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report

Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report

... outcomes of living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC) in patients with multiple myeloma (MM) have not been established in terms of HCC ... See full document

3

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

se of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

... regimens of SOF/LDV and SOF plus DCV ...experience of treating HCV- infected patients before and after liver transplantation in Korea with ...Six patients were treated ... See full document

5

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

... that patients can tolerate the administration of ex vivo-expanded allogenic NK cells as adjuvant immunotherapy after curative liver resection, without drug-related adverse ...feasibility ... See full document

9

Treatment medication patterns and follow-up evaluation on clinical, biochemical, and laboratory parameters in patients with hepatitis B virus infection

Treatment medication patterns and follow-up evaluation on clinical, biochemical, and laboratory parameters in patients with hepatitis B virus infection

... ETV in the first 3 months after treatment was started, but both had comparable efficacy for long-term ...ratio of men and women was positively related with the severity of ... See full document

9

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis

... definitions in various clinical settings, because pattern of prescribing antiviral agent might be quite different depending on the clinical ...133 patients were not enough to validate for 7166 ... See full document

13

Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea

Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea

... cost of serologic test- ing, the cost of vaccination, patient compliance, and the like- lihood of the occurrence of a clinically significant fatal HAV superinfection should also be determined ... See full document

5

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

... Most patients in this study were treatment-naive and HCV mono-infected; caution when ex- trapolating these findings to other patients groups, such as those previously treated for HCV infection or ... See full document

8

Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study

Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study

... B virus and hepatitis C virus co-infection: A multicenter observational study Hang-Dong JIA 1,2 , Lei LIANG 1,2 , Chao LI 3 , Han WU 3 , Hong WANG 4 , Ying-Jian LIANG 5 , Ya-Hao ZHOU 6 , Wei-Min GU 7 ... See full document

1

JKSSJournal of the Korean Surgical Society

Inguinal hernia repair in patients with liver cirrhosis accompanied by ascites

... Twenty-two patients were included in the ...recurrence in all patients. Minor complications occurred in only three patients, consisting of two hematomas and one case ... See full document

6

Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions

Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions

... 24 in spe- cific hospital ...admission in patients with esophageal variceal hemorrhage was associat- ed only with a small delay in endoscopy and no increase in ...events ... See full document

10

Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection

Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection

... (4 patients), these findings should be considered with ...severity of liver disease solely by measure- ments of plasma transaminase levels is ...possibly with an estimated dura- ... See full document

5

Show all 10000 documents...